ArticleCureus2025
Ultrasound-Guided Pulsed Radiofrequency in the Anterior Femoral Cutaneous Nerves to Treat Postherpetic Neuralgia in Anteromedial Thigh: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postherpetic neuralgia (PHN) is a typical neuropathic pain after the eruption of the herpes zoster (HZ) rash. Pulsed radiofrequency (PRF) represents a minimally invasive, target-selective neuromodulatory intervention for PHN, with the dorsal root ganglion (DRG) serving as its primary therapeutic target. However, there is a paucity of evidence about the application of PRF to target peripheral nerves to treat PHN, which is easier to access with a lower risk of complications. We describe the successful management of a case by using PRF in the anterior femoral cutaneous nerves (AFCNs) to treat PHN in the anteromedial thigh in a 70-year-old male. This report highlights that PRF directed at peripheral nerves could also yield significant pain relief in chronic localized refractory PHN. Targeting peripheral nerves with PRF emerges as a viable treatment strategy for this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.